Poole E - Search Results

1

Virus-Specific Nanobody-Chimeras Degrade the Human Cytomegalovirus US28 Protein in CD34+ Cells.

Poole E, Schmitt J, Graham SC, Kelly BT, Sinclair J. Poole E, et al. Pathogens. 2024 Sep 24;13(10):821. doi: 10.3390/pathogens13100821. Pathogens. 2024. PMID: 39452693 Free PMC article.

2

Understanding HCMV Latency Using Unbiased Proteomic Analyses.

Poole E, Sinclair J. Poole E, et al. Pathogens. 2020 Jul 20;9(7):590. doi: 10.3390/pathogens9070590. Pathogens. 2020. PMID: 32698381 Free PMC article. Review.

3

Virally induced changes in cellular microRNAs maintain latency of human cytomegalovirus in CD34⁺ progenitors.

Poole E, McGregor Dallas SR, Colston J, Joseph RSV, Sinclair J. Poole E, et al. J Gen Virol. 2011 Jul;92(Pt 7):1539-1549. doi: 10.1099/vir.0.031377-0. Epub 2011 Apr 6. J Gen Virol. 2011. PMID: 21471310

4

Human cytomegalovirus latency alters the cellular secretome, inducing cluster of differentiation (CD)4+ T-cell migration and suppression of effector function.

Mason GM, Poole E, Sissons JG, Wills MR, Sinclair JH. Mason GM, et al. Among authors: poole e. Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14538-43. doi: 10.1073/pnas.1204836109. Epub 2012 Jul 23. Proc Natl Acad Sci U S A. 2012. PMID: 22826250 Free PMC article.

5

The use of primary human cells (fibroblasts, monocytes, and others) to assess human cytomegalovirus function.

Poole E, Reeves M, Sinclair JH. Poole E, et al. Methods Mol Biol. 2014;1119:81-98. doi: 10.1007/978-1-62703-788-4_6. Methods Mol Biol. 2014. PMID: 24639219

6

Sleepless latency of human cytomegalovirus.

Poole E, Sinclair J. Poole E, et al. Med Microbiol Immunol. 2015 Jun;204(3):421-9. doi: 10.1007/s00430-015-0401-6. Epub 2015 Mar 14. Med Microbiol Immunol. 2015. PMID: 25772624 Free PMC article. Review.

7

Latent infection of myeloid progenitors by human cytomegalovirus protects cells from FAS-mediated apoptosis through the cellular IL-10/PEA-15 pathway.

Poole E, Lau JCH, Sinclair J. Poole E, et al. J Gen Virol. 2015 Aug;96(8):2355-2359. doi: 10.1099/vir.0.000180. Epub 2015 May 8. J Gen Virol. 2015. PMID: 25957098 Free PMC article.

8

The human cytomegalovirus non-coding Beta2.7 RNA as a novel therapeutic for Parkinson's disease--Translational research with no translation.

Poole E, Kuan WL, Barker R, Sinclair J. Poole E, et al. Virus Res. 2016 Jan 2;212:64-9. doi: 10.1016/j.virusres.2015.05.007. Epub 2015 May 21. Virus Res. 2016. PMID: 26003955 Review.

9

Using Primary Human Cells to Analyze Human Cytomegalovirus Biology.

Poole E, Groves I, Jackson S, Wills M, Sinclair J. Poole E, et al. Methods Mol Biol. 2021;2244:51-81. doi: 10.1007/978-1-0716-1111-1_4. Methods Mol Biol. 2021. PMID: 33555582

10

Regulation of host and viral promoters during human cytomegalovirus latency via US28 and CTCF.

Elder EG, Krishna BA, Poole E, Perera M, Sinclair J. Elder EG, et al. Among authors: poole e. J Gen Virol. 2021 May;102(5):001609. doi: 10.1099/jgv.0.001609. J Gen Virol. 2021. PMID: 34042564 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

390 results

Search Page

Filters